Arkolith/Insider Trading/UNCY/Form 4

Aggarwal Gaurav

DirectorUnicycive Therapeutics, Inc. (UNCY) · full profile →Form 4 · filed Jul 13, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
1 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 11, 2023Conversion(C)3.5M——3.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 11, 2023Conversion(C)8K$1000.00$8.1M0
Jul 11, 2023Conversion(C)13.4M—$013.4M
Jul 11, 2023Conversion(C)18.6M—$018.6M
Jul 11, 2023Conversion(C)11.6M—$011.6M
Jul 11, 2023Conversion(C)12.8M—$012.8M

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-056885) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML